Experiences with

Pazopanib

Aug to September – took break from Chemo and in September started with Oral Chemo Pazopanib (600)+Endoxin(100)+Letrozol (2.5). CT scan (17.08.23) showed disease progression with little to no side effects/pain. Increase in stomach and back pain and stomach infection on 5.12.23.

However, her cancer has been kept under control for years with a type of drug called pazopanib and has been relatively limited, although it has started growing again slightly recently. Mum has believed she's had PMR for years, but it hasn't been formally diagnosed.

Would they be similar to those of sunitinib or pazopanib? Thank you all!

Additionally, lenalidomide in combination with pazopanib was predicted to be most potent for CRPC. Conclusion: These findings support the use of a computational reversal gene expression approach to identify new drug and drug combination candidates that can be used to treat CRPC.

Abiraterone has now been stopped with my PSA at 5 So my question is i have been offered treatment that i can not find much information on here in the UK and was after your thoughts, so 20 sessions of RT to the prostate BAT testosterone flood and drought mitoxantrone Tumor biopsy and if suitable either Pazopanib

Are you taking PAZOPANIB?

As this type cancer does not respond to main stream chemo, I am taking a "chemo type" tablet PAZOPANIB ( 2 a day) Is there anyone out there who is on this drug? Have you had success? My prognosis was only 9 weeks ago and I have been on the above for 7weeks.

It would appear that there is a new drug coming on stream called pazopanib which will work even better than Avastin. There is a trial starting in Uk and when they start over there, they probably do same here. It is an oral tablet taken daily.

'If pazopanib is approved for ovarian cancer, many patients will experience longer diseasefree and chemotherapy-free periods.' Pazopanib is currently approved to treat kidney cancer and soft tissue sarcoma.

My husband has recently finished his 4th chemo infusion and, depending on the results of his scan next week, has been offered a place on the EORTC trial using Pazopanib versus placebo.